content_image/72629.jpg
<img src='content_image/72629.jpg'>

C R A I G A . S M I T H , P h . D . (left) Chief Scientific Officer VLST Corp. 

C A R L W E I S S M A N (center) President & CEO Accelerator Corp. 

S T E V E N R . W I L E Y, P h . D . (right) Chief Technology Officer VLST Corp. 

The scientific team of Drs. Craig Smith and Steven Wiley, invented the arthritis drug Enbrel$^{®}$, which is now a multibillion dollar biotechnology product, and are co-founders of an emerging biotechnology company dedicated to the development of next-generation monoclonal antibody therapeutics. This company was founded, in part, by Accelerator Corp., led by President and CEO Carl Weissman. Accelerator Corp., an innovative and creative vehicle designed to foster promising start-ups, is anchored by The Institute for Systems Biology, together with Alexandria and several prominent venture capital firms. 

